Liver transplantation (LT) is a standard treatment for children with end-stage liver disease, standing at more than 90% survival rate after one yr, and at over a 70% survival rate after five yr. The majority of transplanted children enjoy an excellent quality of life but complications can occur in the long term, and can develop subclinically in otherwise well children; there are various underestimated nutritional and metabolic aspects, including the so-called post-transplant metabolic syndrome (PTMS). During the post-transplant period, the use of immunosuppressants, corticosteroids, calcineurin inhibitors, and the presence of risk factors, including non-alcoholic fatty liver disease (NAFLD), and kidney and bone complications have been largely implicated in PTMS development. Strategies to reduce the progression of PMTS should include careful screening of patients for diabetes, dyslipidemia, and obesity, and to support weight reduction with a carefully constructed program, particularly based on diet modification and exercise. With early identification and appropriate and aggressive management, excellent long-term health outcomes and acceptable graft survival can be achieved.

Pediatric post-transplant metabolic syndrome: new clouds on the horizon / Nobili, Valerio; de Ville de Goyet, Jean. - In: PEDIATRIC TRANSPLANTATION. - ISSN 1397-3142. - 17:3(2013), pp. 216-223. [10.1111/petr.12065]

Pediatric post-transplant metabolic syndrome: new clouds on the horizon

Nobili, Valerio
;
2013

Abstract

Liver transplantation (LT) is a standard treatment for children with end-stage liver disease, standing at more than 90% survival rate after one yr, and at over a 70% survival rate after five yr. The majority of transplanted children enjoy an excellent quality of life but complications can occur in the long term, and can develop subclinically in otherwise well children; there are various underestimated nutritional and metabolic aspects, including the so-called post-transplant metabolic syndrome (PTMS). During the post-transplant period, the use of immunosuppressants, corticosteroids, calcineurin inhibitors, and the presence of risk factors, including non-alcoholic fatty liver disease (NAFLD), and kidney and bone complications have been largely implicated in PTMS development. Strategies to reduce the progression of PMTS should include careful screening of patients for diabetes, dyslipidemia, and obesity, and to support weight reduction with a carefully constructed program, particularly based on diet modification and exercise. With early identification and appropriate and aggressive management, excellent long-term health outcomes and acceptable graft survival can be achieved.
2013
liver transplantation; pediatric; post-transplant metabolic syndrome; adolescent; child; diabetes complications; disease progression; end stage liver disease; graft survival; humans; immunosuppressive agents; liver transplantation; metabolic syndrome; obesity; quality of life; risk factors; treatment outcome; pediatrics; perinatology and child health; transplantation
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Pediatric post-transplant metabolic syndrome: new clouds on the horizon / Nobili, Valerio; de Ville de Goyet, Jean. - In: PEDIATRIC TRANSPLANTATION. - ISSN 1397-3142. - 17:3(2013), pp. 216-223. [10.1111/petr.12065]
File allegati a questo prodotto
File Dimensione Formato  
Nobili_Pediatric post-transplant_2013.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 146.09 kB
Formato Adobe PDF
146.09 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1178095
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 23
social impact